Edition:
United Kingdom

Taisho Pharmaceutical Holdings Co Ltd (4581.T)

4581.T on Tokyo Stock Exchange

11,330JPY
19 Feb 2019
Change (% chg)

¥-30 (-0.26%)
Prev Close
¥11,360
Open
¥11,290
Day's High
¥11,390
Day's Low
¥11,260
Volume
56,500
Avg. Vol
114,520
52-wk High
¥14,130
52-wk Low
¥9,170

Chart for

About

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. is a holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Self-Medication segment is engaged in the research, development, manufacture and sale of general pharmaceuticals, general foods, medical supplies and others. The Medical segment is engaged in the... (more)

Overall

Beta: 0.23
Market Cap(Mil.): ¥772,496.81
Shares Outstanding(Mil.): 90.14
Dividend: 60.00
Yield (%): 1.28

Financials

  4581.T Industry Sector
P/E (TTM): 25.04 30.48 33.70
EPS (TTM): 342.28 -- --
ROI: 4.17 14.95 14.45
ROE: 4.27 16.27 15.96

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

UPDATE 2-Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion (1.3 billion pounds), the companies said on Wednesday.

19 Dec 2018

Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

Deals of the day-Mergers and acquisitions

Dec 17 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

17 Dec 2018

Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA - Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion (1.3-billion pound) deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

17 Dec 2018

Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA: Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

17 Dec 2018

Taisho said to near $1.6 bln deal for Bristol-Myers's UPSA- Bloomberg

Dec 16 Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

17 Dec 2018

Earnings vs. Estimates